Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare Biotechnology

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc

Bullboard Posts

Post by Snowballgrowthon Feb 09, 2018 8:19pm

246 Views

Post# 27537199

It takes time to build a solid business

So I added today below $ 7.50 including some at $ 7.41..thanks to impatient investors. You are the reason I got some returns over last 20 years.

Fake news. You know better than GUD's management how and when to allocate capital in specialty pharma. You have some real suggestions to get + 15 % us return on capital eveny year for next 5 years.

Bullboard Posts

Global Tungsten Market and Supply Security